The SLAS Fellow Member Program launched in 2016 to recognize the exceptional contributions of SLAS’s most valued contributors. SLAS Fellow Members represent the epitome of SLAS as a mission-driven organization that focuses on serving life sciences professionals via practitioner-driven knowledge, education and peer-to-peer connections.
Join or renew your SLAS Premier Membership to begin your journey to becoming an SLAS Fellow Member.
In celebration of International Volunteer Day, we at SLAS want to sincerely thank all our incredible volunteers. To all our incredible volunteers, your passion, dedication, and unwavering support drive our success and ability to make a meaningful impact within the life sciences community. Whether you've shared your expertise as a mentor, contributed to a committee, or facilitated impactful discussions, your efforts are genuinely transformative.
Your commitment inspires us every day, and we are honored to have you as part of SLAS.
From all of us at SLAS,
Happy International Volunteer Day!
Paul Anderson, M.S., Neurocrine Biosciences
Evan F. Cromwell, Ph.D., Protein Fluidics
Olivier Frey, Ph.D., InSphero
Zack Gurard-Levin, Ph.D., Charles River Laboratories
Elizabeth Sharlow, Ph.D., University of Virginia
Anastasia Velentza, Ph.D., Vilya
Vladislav Zarayskiy, Ph.D., Monte Rosa Therapeutics
Elizabeth Admirand, Frontier Medicines
Michelle Arkin, Ph.D., University of California San Francisco
Douglas S. Auld, Ph.D., Novartis Biomedical Research
Manuela Beil-Peter, SOULution
Matt Boeckeler, AstraZeneca
Roger Bosse, Ph.D., BioSignal2 Inc.
John Thomas Bradshaw, Ph.D., JTP Technical Solutions
Marybeth Burton, Merck
Robert Campbell, Ph.D., Redona Therapeutics
Anne Carpenter, Ph.D., Broad Institute
Taosheng Chen, Ph.D., St. Jude Children’s Research Hospital
Edward Kai-Hua Chow, Ph.D., National University of Singapore
J. Colin Cox, Ph.D., Hexagon Bio
Sue Crimmin, Ph.D., Independent Consultant
Melissa Crisp, Ph.D., Eli Lilly and Company
Robert Damoiseaux, Ph.D., UCLA
Sammy Datwani, Ph.D., Synthego Corporation
Alain Donzel, Ph.D., Scitec Research S.A.
Richard M. Eglen, Ph.D., Arsenal Capital Partners
Amaury Ernesto Fernández-Montalván, Ph.D., Boehringer Ingelheim
Kenda Evans, Ph.D., Agilent Technologies, Inc.
Frank Fan, Ph.D., Promega Corporation
Haian Fu, Emory University School of Medicine
Ralph Garippa, Ph.D., Memorial Sloan-Kettering
Marcie Glicksman, Ph.D., EnClear Therapies
Alexander Godfrey, Ph.D., Automated Chemistry, National Center For Advancing Translational Sciences
Rose Gonzales, Ph.D., Thames Pharma Partners, LLC
Maciej Grajewski, SG Papertronics B.V.
Peter Grandsard, Amgen
Clive Green, Ph.D., AstraZeneca
Philip Gribbon, Ph.D., Fraunhofer ITMP
Steven Hamilton, Ph.D., The Hamilton Consulting Group
David Herold, Ph.D., M.D., Veterans Administration Medical Center/University of California, San Diego
Geoffrey Holdgate, AstraZeneca
Kamran Honarnejad, Ph.D., Evotec
Stephen Hughes, Ph.D., Genscript
David Jennions, Ph.D., GRAIL
Joshua D. Kangas, Ph.D., Carnegie Mellon University
Katy Kettleborough, LifeArc
Deok-Ho Kim, Ph.D., University of Washington
Gary Kramer, Ph.D.
Eberhard Krausz, Ph.D., Evotec
Jörg Kutter, Ph.D., University of Copenhagen
Melanie Leveridge, GlaxoSmithKline
Jan Lichtenberg, Ph.D., InSphero
Andreas H. Luippold, Ph.D., Boehringer Ingelheim Pharma GmbH & Co. KG
Ricardo Macarron, Ph.D, InCyte
Julio Martin, Ph.D
Duncan J. McNicol, Merck
Georges Muller, Ph.D., SEED Biosciences Ltd.
Coleman Murray Ph.D., Ferrologix
Kristen Nailor, Genentech
Andrew Napper, Ph.D., Bristol Myers Squibb
Jonathan O'Connell, Ph.D., Dewpoint Therapeutics
Christian Parker, Ph.D., Novartis Biomedical Research
Yohann Potier, Ph.D., Tessera Therapeutics
Shalini Prasad, Ph.D., University of Texas, Dallas
Stephen Rees, Ph.D., O.B.E., AstraZeneca
Mario Richter, Abbvie
Terry Riss, Ph.D., Promega
Mark Russo, Ph.D., The College of New Jersey
Mariafrancesca Scalise, Ph.D., University of Calabria
Louis Scampavia, Ph.D., Scripps Research
Craig Schulz, Ph.D., Terray Therapeutics
Ian Shuttler, Ph.D., Ian Shuttler Consultancy Ltd.
Daniel Sipes, M.S., Plexium
Timothy Spicer, Ph.D., The Scripps Research Institute
James D. Sterling, Ph.D., Keck Graduate Institute
Kim Titus, Corning Life Sciences
Dana Vanderwall, Ph.D., Bristol-Myers Squibb
Steven P. van Helden, wega Informatic AG
Sabeth Verpoorte, Ph.D., University of Groningen
Fabien Vincent, Ph.D., Pfizer
Andrea Weston, Ph.D., Pfizer
Mary Jo Wildey, Ph.D., Merck
Jonathan Wingfield, Ph.D., AstraZeneca
Pak Kin Wong, Ph.D., Pennsylvania State University
Andy Zaayenga, SmarterLab
Zhenggrong Zhu, Ph.D., Merck
Adam Zweifach, Ph.D., University of Connecticut
To earn an invitation to become an SLAS Fellow Member, candidates must meet several prerequisites:
See the table below for engagement point values associated with content and service contributions.
5 total points, with at least one from content contribution and one from volunteer service activities, are required to earn an invitation to become an SLAS Fellow Member.
| Content – Technical Presentations (1 point per) | Content – Journal Manuscripts or Issue Guest Editor (2 points per) | Service – Volunteer Leadership (2 points per role) |
|---|---|---|
|
|
Served in a volunteer leadership position in a significant SLAS committee/ oversight entity:
|
SLAS Fellow Members are required to pay SLAS membership dues annually.
Please contact Gina Anzalone, SLAS Membership Manager, with any questions or to check your current eligibility toward becoming an SLAS Fellow Member.
